Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Synagis
Synagis is the brand name for palivizumab. [1]
Palivizumab is a monoclonal antibody used to help prevent respiratory syncytial virus (RSV) infection in certain high-risk children. [1]
The information provided here identifies Synagis’s generic name as palivizumab. If you’re looking for whether an FDA-approved generic (or biosimilar) version exists and where, you may need to check current availability and approval status by regulator and market. [1]
1
Other Questions About Synagis :